CPM Programs1. 2 Center for Pharmaceutical Management Programs James Rankin.

Slides:



Advertisements
Similar presentations
Health Systemwide Effects of the Global Fund in Benin and Ethiopia XV International AIDS Conference Bangkok July 12, 2004 Owen Smith, Abt Associates Inc.,
Advertisements

National PSM Coordination Mechanism Dr Vincent Habiyambere WHO/HIV Department AIDS Medicines & Diagnostics Service (AMDS) Bangkok, July 2005.
Technical cooperation with countries Technical Cooperation for essential drugs and traditional medicines September 2005.
WHO STRATEGY FOR WORKING WITH COUNTRIES:REGIONAL AND COUNTRY PERSPECTIVE TECHNICAL BRIEFING SEMINAR,Geneva,19-23 September 2005 Dr. Jean-Marie TRAPSIDA.
Follow-up after training and supportive supervision The IMAI District Coordinator Course.
Progress to date on Contraceptive Security in Latin America Anabella Sánchez, Manager for LAC CS Regional Initiative Nora Quesada, Manager for LAC country.
Antibiotic Policy in Ghana; the way forward
Comprehensive M&E Systems
Development Effectiveness in a world of targeted aid: the contribution of the Global Fund Dr. Viviana Mangiaterra Senior Coordinator, RMNCH and HSS Technical,
The role of UNOPS in humanitarian operations Oslo, 27th November 2014.
KNCV Tuberculosis Foundation’s support to The National Tuberculosis Control Program By Verena Mauch, Sr TB Consultant.
EDM STRATEGY FOR WORKING WITH COUNTRIES-TANZANIA Rose Shija EDM NPO TANZANIA.
Generating evidence for change: Implementing the post-ICIUM research agenda Dennis Ross-Degnan, ScD Harvard Medical School and Harvard Pilgrim Health Care.
African Business Leaders on Health GBC Conference on TB, HIV-TB Co-infection & Global Fund Partnership Johannesburg, October 2010 Technical Assistance.
Unit 9. Human resource development for TB infection control TB Infection Control Training for Managers at National and Subnational Level.
Portfolio Development Framework For FINESSE Business Plans.
Repositioning Family Planning in West Africa Repositionnement de la Planification Familiale en Afrique de l’Ouest Sponsored by: U.S. Agency for International.
046:127 Pharmaceutical Management for Underserved Populations  Paper on Current Controversy  Team Assignment: Observational Visits  National Drug Policy/Assessment.
Medicines Transparency Alliance01/10/2015 Availability of Medicines Anita Wagner Harvard Medical School & WHO Collaborating Center in Pharmaceutical Policy.
Public-Private Partnerships -Selected Experiences in the Western Pacific & Cambodia- National Forum on Public-Private Partnership in Health 7 November,
The Regional Platform for Access and Innovation for Health Analía Porrás Medicines and Health Technologies (HSS/MT) Health Systems based on Primary Health.
1 Webinar: Challenges in Clinical Training Ben Wallace, Executive Director, Clinical Training Reform Health Workforce Australia.
Introduction to Elements of In-Country Drug Management with Focus on TB Drugs Jim Rankin Director, Center for Pharmaceutical Management Management Sciences.
The Challenge of Scale-Up and International Distribution Richard C. Owens, Jr. Director, Supply Chain Management System XVIth International AIDS Conference.
U pdates on the development of the NTP National Strategic Plan GC National TB Conference Pokhara, July 14-15, 2014 Giampaolo Mezzabotta Medical.
Tanzania1. 2 Tanzania Assessment Gabriel Upunda Tanzania3 DemographicsTanzania Area (sq km)945,100 Population 32,900,000 25% urban GNP per capitaUS $240.
A Review of the Standing Committee of Caribbean Statisticians (SCCS) as a Mechanism for Statistical Development and Harmonisation The Second Meeting of.
OVERVIEW OF THE ZIMBABWE NATIONAL MEDICINES POLICY Dr C E Ndhlovu, M Med Sci, FRCP Chairperson, NMTPAC Deputy Dean, UZCHS National workshop, Jan 22-23,
Improving Access and Use of Medicines through Private Sector Initiatives: A case for an Essential Medicines Franchise in Ghana Eghan Kwesi, Mensah D, Idun.
Strategies for Enhancing Access to Medicines Overview of Potential Strategies for Improving Access and Use David Lee.
Paula Munderi Department of Essential Drugs and Medicines Policy World Health Organization Access to essential medicines for HIV/AIDS - update on WHO activities.
BASELINE SURVEYS AND MONITORING OF PHARMACEUTICAL SITUATION IN COUNTRIES. Joseph Serutoke NPO/EDM WHO Uganda November 2002.
What is HMN? Global partnership founded on the premise that better health information means better decisions and better health Partners reflect wide.
Brussels, May 2008MDA Update, RHSC membership meeting Market Development Approaches Working Group Update November 2007 – May 2008 Ben Light MDAWG Leader,
Yemaneberhan Taddesse.  PASDEP(plan of accelerated and sustainable development for the Eradication of poverty) Poverty reduction strategy is the main.
A BASELINE SURVEY OF THE PHARMACEUTICAL SECTOR IN TANZANIA
From 3by5 to Universal Access to HIV/AIDS Treatment: AMDS Technical Briefing Seminar for Consultants on Procurement and Supply Management for HIV, TB and.
1 Sustainable Investment and Donor Coordination in the Philippines A Presentation by : Undersecretary Nieves L. Osorio Department of Finance 25 March.
1 Pharmaceutical System Strengthening: Is There a Need for a New Paradigm? Douglas Keene, PharmD, MHS ICIUM-3 Pre-Conference Session 14 November 2011.
Resource Mobilization and Awareness Working Group Mercedes Mas de Xaxás Population Action International.
1 SUPPLY DIVISION Procurement and Supply Management Technical Assistance.
TBS 2008-H. Tata & M. Babaley Mapping and In-depth Assessment of Medicines Procurement and Supply Systems WHO Technical Briefing Seminar 17 th -21 st November.
Consultant Advance Research Team. Outline UNDERSTANDING M&E DATA NEEDS PEOPLE, PARTNERSHIP AND PLANNING 1.Organizational structures with HIV M&E functions.
Country Partnership Strategy FY12-16 Consultations with Civil Society The World Bank Group June 2, 2011.
2009 An Overview of programmes. Overview Current country programmes – Ghana, Rwanda Transitioned country programmes – Namibia Potential new country programmes.
Action Plans for Improving TB Drug Management Thomas Moore Stop TB/GDF Technical Officer Seconded by MSH.
WHO Technical Briefing Seminar October 2006 Helen Tata Department of Technical Cooperation for Essential Drugs and Traditional Medicines World Health.
WHO Medicines Strategy Progress: Priorities: Dr Guitelle Baghdadi Essential Drugs and Medicines Policy World Health Organization November.
WHO Regional Workshop on Good Manufacturing Practices for Blood Establishments Dr Ana Padilla, Blood Products & related Biologicals Essential Medicines.
MONITORING THE PHARMACEUTICAL SECTOR IN A DEVELOPING COUNTRY - THE GHANA EXAMPLE Gyansa-Lutterodt M. 1,7, Andrews E 2, Arhinful D 3,7, Addo-Atuah J 4,7,
Comprehensive M&E Systems: Identifying Resources to Support M&E Plans for National TB Programs Lisa V. Adams, MD E&E Regional Workshop Kiev, Ukraine May.
NFM: Modular Template Measurement Framework: Modules, Interventions and Indicators LFA M&E Training February
BIMILACI 2007 THE CHALLENGE OF CAPACITY DEVELOPMENT Washington, May 11, 2007 Bayo Adeola FIDIC Executive Committee.
Prepared by: Imon Rahman Lecturer Department of Pharmacy BRAC University.
TECHNICAL Review: M&E Strategy and Indicators DR HARRIET KIVUMBI, PUBLIC HEALTH SPECIALIST, ACCESS-SMC.
Building Pharmaceutical Sector Capacity in Namibia: An Innovative Initiative to Recruit and Retain Pharmacy Staff for Public Service Nwokike, J. 1, D.
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs.
CQUIN: The HIV Coverage, Quality, and Impact Network Miriam Rabkin, MD, MPH Director for Health Systems Strategies ICAP Columbia University.
EDM Strategy for Working with Countries: the Uganda Example
WHO Medicines Work in Countries: The Kenya Example
East African Drug Seller Initiative Uganda Sensitization Meeting
Medicines Procurement and Supply Management Issues in Nigeria
Finance analysis of pharmaceutical management interventions
Richard Laing EMP/WHO TBS 2012
Access to HIV/AIDS Medicines The 3x5 strategy
National Medicines Policies
Richard Laing WHO/PAU TBS 2013
Deliver Ethiopia 7/27/2019.
National Medicines Policies
The Case of the Catholic Pharmaceutical Service in Ghana
Presentation transcript:

CPM Programs1

2 Center for Pharmaceutical Management Programs James Rankin

CPM Programs3 Center for Pharmaceutical Management CPM works to improve health worldwide through enhancing access to and improving use of essential medicines and other health care products

CPM Programs4 Supply Management Cycle Selection Procurement Management Support Distribution Use Policy and Legal Framework

CPM Programs5 CPM Focus Areas Rationalizing drug selection and procurement Facilitating sound distribution and warehousing practices Improving information management and inventory control Expanding access to and use of objective drug information resources Promoting rational drug prescribing and dispensing Promoting appropriate drug use (prescribed medications and self-care)

CPM Programs6 Center for Pharmaceutical Management

CPM Programs7 Rational Pharmaceutical Management Plus (RPM Plus) USAID-funded, 5-year program Core funded initiatives include global collaboration and INRUD coordination Initiatives in more than 20 developing countries Objectives:  Improve the availability of health commodities of assured quality  Strengthen management of health commodities in public and private sectors  Develop and disseminate best practices information

CPM Programs8 Targeted Pharmaceutical Management Assistance World Bank Procurement Documents and Training MSH/IDA Training Course in Managing Drug Supply for Primary Health Care Public-private options analysis – El Salvador and Philippines Rational use training on regional basis

CPM Programs9 Strategies for Enhancing Access to Medicines Improving access to medicines through local public-private collaboration Supported by the Bill & Melinda Gates Foundation 5-year program

CPM Programs10 SEAM Program Components Country-level public-private initiatives to improve access to essential drugs and commodities Feasibility assessment of franchising outlets for essential drugs and commodities Technical collaboration with global drug/vaccines initiatives Development and deployment of information and communications tools to support technical interventions

CPM Programs11 Framework and indicators to measure access Pharmaceutical sector assessments and baseline measurements of access Public-private interventions aimed at specific access gaps Country Strategies

CPM Programs12 Franchising Concept elaboration Business plan Testing of financial assumptions Country feasibility study First collaboration: Cry for the World Foundation/Kenya Consider other potential opportunities and countries

CPM Programs13 Global Technical Collaboration Collaboration in First Year  Collaboration with WHO/EDM  Design GDF procurement and quality assurance methods  GDF country visits Potential collaborations  Ongoing coordination with WHO EDM  Long term staff support to Stop TB  Roll Back Malaria  Green Light Committee  Global Fund

CPM Programs14 Communications & Information Dissemination WHO-MSH Consultative Meetings Annual SEAM program conference Drug management software suite IT support to facilitate improved access to and use of essential medicines Promotion of access to drug information CPM publications

CPM Programs15 CPM Publications

CPM Programs16 Advisory Committee Oscar Arias Sánchez Zafrullah Chowdhury Henk den Besten Graham Dukes Jaime Galvez Tan David Heymann Jorge Jimenez de la Jara Anglade Malan Kla Precious Matsoso Jane Nicholson Eva Ombaka Ok Pannenborg Roy Penchansky Jonathan Quick Philippa Saunders Chitr Sitthi-amorn